Giffen releases STD-prevention app
NEW YORK — A new app allows people to share their STD statuses with potential partners.
Giffen Solutions announced the launch of MedXSafe, a new feature to its MedXCom Patient platform. The app allows people to bump phones with a potential partner and exchange contact information as well as their STD status. Giffen emphasized that users choose to share their information and that the app doesn’t violate medical confidentiality laws, and only licensed healthcare providers can register to use the MedXCom system.
"In our view, anything that helps the war against STDs is a good idea," MedXCom creator and Giffen chief technical officer Michael Nusbaum said. "There has been a relaxed attitude towards STDs lately as many people think medicine can cure all — it can’t."
Specialty to overtake traditional drugs in five years, report finds
BRENTWOOD, Tenn. — Specialty drug spend will surpass traditional drug spend by 2018 for commercial plan sponsors, according to a new study.
Healthcare research firm Artemetrx announced Wednesday the release of its 2013 Specialty Drug Trend Study, finding that specialty drugs already represent 30% of total drug spend after the specialty claims covered under the medical benefit are fully captured, compared with the 15% to 20% frequently reported for specialty drugs as a percentage of total drug spend.
"Given these findings, plan sponsors need visibility into their entire specialty drug spend, not just that residing under the pharmacy benefit," Artemetrx president Brenda Motheral said. "When specialty medication use goes unmeasured, plans cannot effectively manage their specialty benefit."
The study’s researchers forecasted that total specialty drug spend will grow from $290 per member per year to $845 by 2018 due to a strong drug pipeline, price inflation and an expanded number of approved uses for drugs.
"Specialty spend is going to overtake traditional drug spend quicker than most plan sponsors realize due to the siloed reporting of specialty drugs that currently exists in the marketplace," Motheral said. "Opportunities to better manage specialty drugs abound, but they are often unique from those used for non-specialty drugs."
Reports: NY to use GPS-fitted pill bottles to track thieves
NEW YORK — New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.
The Washington Post reported that Police Commissioner Raymond Kelly said, in prepared remarks provided before a conference Tuesday in California sponsored by former president Bill Clinton’s foundation, that the initiative was sparked by a series of crimes associated with the black market for prescription painkillers.
The initiative is reportedly dubbed “Operation Safety Cap.”
According to a Reuters report, federal and New York Police Department investigators last year seized 9,000 painkillers being sold at an open-air drug market in northern Manhattan.
A database of about 6,000 pharmacies in the New York City area currently is being created by the NYPD, according to the Post. Police offers are expected to visit those pharmacies to recommend better security measures, including the adoption of the GPS-fitted bottles.
To read the entire article by the Post, click here.